John Foley, MD
Neurology · Salt Lake City, UTNPI 1073538047
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Biogen at 53.8% of the total. Reporting peaked in 2019 at $39,650 and has fallen 85.2% since, to $5,871 in 2025. Among neurology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 550 payments — averaging $179.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$53K
- Novartis$14K
- EMD Serono, Inc.$11K
- Amgen$8K
- Sanofi$6K
- TG Therapeutics, Inc.$4K
- plus $3K from 33 others
Across 90 payments — averaging $20,111 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$1.5M
- Genentech, Inc.$118K
- Adamas Pharmaceuticals, Inc.$86K
- Novartis$49K
- Roche Products Limited$38K
- Sanofi$20K
- plus $6K from 2 others
What the payments were for
- Consulting fees$57,07558%
- Speaking & faculty fees$20,15220%
- Travel & lodging$5,1185%
- Food & beverage$13,51114%
- Education$1440%
- Gifts$2,7333%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 99 | $53,115 |
| Novartis | 104 | $13,657 |
| EMD Serono, Inc. | 49 | $11,316 |
| Amgen(2 entities) | 34 | $7,661 |
| Sanofi | 23 | $5,999 |
| TG Therapeutics, Inc. | 40 | $4,009 |
| Genentech USA, Inc. | 26 | $546 |
| Teva Pharmaceuticals USA, Inc. | 66 | $276 |
| Bristol Myers Squibb | 12 | $267 |
| AstraZeneca | 11 | $199 |
| Argenx US, Inc. | 8 | $176 |
| Mallinckrodt Enterprises LLC | 12 | $131 |
| Genentech, Inc. | 5 | $125 |
| CSL Behring | 7 | $124 |
| AbbVie | 5 | $123 |
| Eisai Inc. | 3 | $118 |
| Sunovion Pharmaceuticals Inc. | 5 | $83 |
| Janssen Scientific Affairs, LLC | 3 | $76 |
| UCB, Inc. | 3 | $67 |
| Banner Life Sciences, LLC | 4 | $65 |
| Pfizer | 4 | $59 |
| Lilly USA, LLC | 3 | $57 |
| ANI Pharmaceuticals, Inc. | 2 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $48 |
| SK Life Science, Inc. | 2 | $45 |
| Mylan Specialty L.p. | 1 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Acorda Therapeutics, Inc | 2 | $35 |
| Grifols USA, LLC | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Merz Pharmaceuticals, LLC | 1 | $24 |
| Lundbeck LLC | 1 | $19 |
| Sandoz | 1 | $18 |
| Akcea Therapeutics, Inc. | 1 | $17 |
| MDD US Operations, LLC | 1 | $16 |
| Abbott | 1 | $14 |
| Mallinckrodt Hospital Products Inc. | 1 | $13 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$98,732 in reported general payments places this provider in the 90th percentile of 157 neurology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammakedImmune Globul G/Gly/Iga Avg 46 | 22 | $58,066 |
| Baclofen | 18 | $375 |
Paid to pharmacies, not to this prescriber.
Other neurology in Salt Lake City
- Timothy WestSalt Lake City$856K
- Stacey SteevesSalt Lake City$548K
- Amir ArainSalt Lake City$329K
- Mark BrombergSalt Lake City$265K
- April ErwinSalt Lake City$263K
- Albert SmithSalt Lake City$122K
- Kevin BrennanSalt Lake City$81K
- Lucy DewittSalt Lake City$81K
- Nicholas JohnsonSalt Lake City$80K
- Viktoria KaplanSalt Lake City$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.